Monday, 6 March 2017

FDA lifts hold on Seattle Genetics drug trials

(Reuters) - Seattle Genetics Inc said on Monday the U.S. Food and Drug Administration had lifted the clinical hold on several early stage studies testing its experimental cancer drug.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)